Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Nr2e3 functional domain ablation by CRISPR-Cas9D10A identifies a new isoform and generates retinitis pigmentosa and enhanced S-cone syndrome models

dc.contributor.authorAísa-Marín, Izarbe
dc.contributor.authorLópez-Iniesta, M.José
dc.contributor.authorMilla, Santiago
dc.contributor.authorLillo, Jaume
dc.contributor.authorNavarro Brugal, Gemma
dc.contributor.authorde la Villa, Pedro
dc.contributor.authorMarfany i Nadal, Gemma
dc.date.accessioned2020-11-30T18:10:33Z
dc.date.available2021-10-31T06:10:19Z
dc.date.issued2020-10
dc.date.updated2020-11-30T18:10:33Z
dc.description.abstractMutations in NR2E3 cause retinitis pigmentosa (RP) and enhanced S-cone syndrome (ESCS) in humans. This gene produces a large isoform encoded in 8 exons and a previously unreported shorter isoform of 7 exons, whose function is unknown. We generated two mouse models by targeting exon 8 of Nr2e3 using CRISPR/Cas9-D10A nickase. Allele Δ27 is an in-frame deletion of 27 bp that ablates the dimerization domain H10, whereas allele ΔE8 (full deletion of exon 8) produces only the short isoform, which lacks the C-terminal part of the ligand binding domain (LBD) that encodes both H10 and the AF2 domain involved in the Nr2e3 repressor activity. The Δ27 mutant shows developmental alterations and a non-progressive electrophysiological dysfunction that resembles the ESCS phenotype. The ΔE8 mutant exhibits progressive retinal degeneration, as occurs in human RP patients. Our mutants suggest a role for Nr2e3 as a cone-patterning regulator and provide valuable models for studying mechanisms of NR2E3-associated retinal dystrophies and evaluating potential therapies.
dc.format.extent16 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec704940
dc.identifier.issn0969-9961
dc.identifier.urihttps://hdl.handle.net/2445/172472
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.nbd.2020.105122
dc.relation.ispartofNeurobiology of Disease, 2020, vol. 146, p. 105122
dc.relation.urihttps://doi.org/10.1016/j.nbd.2020.105122
dc.rightscc-by-nc-nd (c) Elsevier, 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject.classificationMalalties de la retina
dc.subject.otherRetinal diseases
dc.titleNr2e3 functional domain ablation by CRISPR-Cas9D10A identifies a new isoform and generates retinitis pigmentosa and enhanced S-cone syndrome models
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
704940.pdf
Mida:
5.31 MB
Format:
Adobe Portable Document Format